FDA Inspection 673146 — William A. Gahl, MD, PhD
The FDA completed an inspection of William A. Gahl, MD, PhD on Jul 8, 2010 in Bethesda, MD. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jul 8, 2010
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Bethesda, MD (United States)
Additional Details
Clinical Investigator (CI)
Citations
| ID | CFR | Description |
|---|---|---|
| 7387 | 21 CFR 50.25(a)(1) | Statement of research, purpose, duration of participation |
| 7526 | 21 CFR 312.62(a) | Accountability records |
| 7560 | 21 CFR 312.60 | FD-1572, protocol compliance |